Press release
In-vitro Diagnostics Market Size, Growth, Opportunities 2024-2032 | F. Hoffmann-La Roche Ltd, Abbott Laboratories, Thermo Fisher Scientific Inc., Sysmex Corporation, Siemens Healthineers AG, BD (Becton, Dickinson, and Company), Seegene Inc. (Republic of K
The global in-vitro diagnostics market size hit USD 73.99 billion in 2024. The market value is slated to rise from USD 74.92 billion in 2023 to USD 117.60 billion by 2032, exhibiting a CAGR of 6.0% during the forecast period. In-vitro Diagnostics (IVD) include medical devices that use biological samples, such as blood, urine, and tissues, to perform diagnostic tests. The IVD tests aid in the detection and monitoring of infectious diseases, autoimmune diseases, and a variety of medical conditions as well as the analysis of drug therapies, says Fortune Business InsightsTM in its report titled, "In-vitro Diagnostics Market, 2022-2029".๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐ญ๐ก๐ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/in-vitro-diagnostics-ivd-market-101443
The In-Vitro Diagnostics (IVD) market is experiencing robust growth, driven by the increasing prevalence of chronic and infectious diseases, technological advancements, and a growing emphasis on early and accurate disease detection. IVDs play a crucial role in diagnosing a wide range of health conditions, offering insights that enable personalized treatment plans and improved patient outcomes.
The market includes a diverse range of products, such as reagents, instruments, and software, used across applications like infectious disease testing, oncology, cardiology, and genetic testing. With the rising demand for point-of-care testing, home diagnostic solutions, and the integration of AI and machine learning in diagnostics, the IVD market is evolving rapidly. Additionally, the impact of the COVID-19 pandemic has accelerated innovation and adoption, making IVDs a vital component in the global healthcare landscape.
๐๐๐๐๐ข๐ง๐ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ ๐ข๐ง ๐ญ๐ก๐ ๐๐ง-๐ฏ๐ข๐ญ๐ซ๐จ ๐๐ข๐๐ ๐ง๐จ๐ฌ๐ญ๐ข๐๐ฌ (๐๐๐) ๐๐๐ซ๐ค๐๐ญ:
Hoffmann-La Roche Ltd (Switzerland)
Abbott Laboratories (U.S.)
Thermo Fisher Scientific Inc. (U.S.)
Sysmex Corporation (Japan)
Siemens Healthineers AG (Germany)
BD (Becton, Dickinson, and Company) (U.S.)
Seegene Inc. (Republic of Korea)
DiaSorin S.p.A. (Italy)
Quest Diagnostics Incorporated (U.S.)
Bio-Rad Laboratories, Inc. (U.S.)
๐๐ซ๐ข๐ฏ๐๐ซ๐ฌ & ๐๐๐ฌ๐ญ๐ซ๐๐ข๐ง๐ญ๐ฌ-
Market Growth will be Boosted by Rising Chronic Disease Incidences
Several diseases, including genetic, cardiovascular, and neurological disorders are becoming increasingly common. Cardiovascular Diseases (CVDs) are the leading cause of death worldwide, killing 17.9 million people each year, according to the World Health Organization (WHO). This has resulted in increased population awareness of early diagnosis and an increase in routine diagnosis, which support the market's overall growth. Furthermore, the introduction of novel advanced IVD products contributes to the market's rapid growth.
In-vitro diagnostics instruments must be operated by trained professionals. As a result, the device's maintenance cost rises, which hampers the in-vitro diagnostics market growth.
๐๐๐ญ ๐ฒ๐จ๐ฎ๐ซ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐๐ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ฉ๐จ๐ซ๐ญ:https://www.fortunebusinessinsights.com/enquiry/ask-for-customization/in-vitro-diagnostics-ivd-market-101443
๐๐๐ฉ๐จ๐ซ๐ญ ๐๐จ๐ฏ๐๐ซ๐๐ ๐-
The report focuses on important aspects such as an overview of the advanced product, the prevalence of various diseases and disorders, key countries, and pricing analysis. It also includes a summary of reimbursement scenarios for diagnostic procedures, key industry developments, such as mergers, partnerships, and acquisitions, impact of COVID-19, and brand analysis.
๐๐จ๐ฆ๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฏ๐ ๐๐๐ง๐๐ฌ๐๐๐ฉ๐-
F.Hoffmann-La Roche Ltd. Signed a Merger Agreement with GenMark Diagnostics Inc
In March 2021, F. Hoffmann-La Roche Ltd. and GenMark Diagnostics Inc. signed a definitive merger agreement. This acquisition will provide Roche with access to GenMark's novel technology for testing for a wide range of pathogens using a single patient sample.
๐ ๐ซ๐๐ช๐ฎ๐๐ง๐ญ๐ฅ๐ฒ ๐๐ฌ๐ค๐๐ ๐๐ฎ๐๐ฌ๐ญ๐ข๐จ๐ง๐ฌ ๐๐จ๐ซ ๐๐ง-๐๐ข๐ญ๐ซ๐จ ๐๐ข๐๐ ๐ง๐จ๐ฌ๐ญ๐ข๐๐ฌ (๐๐๐) ๐๐๐ซ๐ค๐๐ญ
What is the current size of the global In-Vitro Diagnostics (IVD) market?
The global IVD market has seen substantial growth in recent years, driven by increased demand for diagnostic testing. To get the latest market size, it is essential to refer to up-to-date market reports.
What factors are driving the growth of the In-Vitro Diagnostics (IVD) market?
Factors driving growth include the rising prevalence of chronic and infectious diseases, advancements in diagnostic technologies, increased awareness of personalized medicine, and the growing demand for point-of-care testing.
What are the main types of In-Vitro Diagnostics (IVD) products?
The IVD market consists of various products, including reagents, instruments, software, and services used for diagnostics across different applications such as infectious diseases, oncology, cardiology, and genetic testing.
Which regions are leading the In-Vitro Diagnostics (IVD) market?
North America and Europe are the leading regions due to advanced healthcare infrastructure and high adoption rates of diagnostic technologies, while the Asia-Pacific region is experiencing rapid growth due to increased healthcare expenditure and a rising patient population.
Who are the key players in the In-Vitro Diagnostics (IVD) market?
Major players in the IVD market include Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Bio-Rad Laboratories, and Thermo Fisher Scientific, among others.
How has the COVID-19 pandemic impacted the In-Vitro Diagnostics (IVD) market?
The pandemic significantly boosted the IVD market, particularly in the areas of molecular diagnostics and rapid testing. There was a surge in demand for COVID-19 test kits, which accelerated growth and innovation in the sector.
What are the emerging trends in the In-Vitro Diagnostics (IVD) market?
Key trends include the growing adoption of point-of-care testing, the integration of AI and machine learning in diagnostics, the rise of home testing kits, and the increasing focus on precision medicine and companion diagnostics.
What challenges does the In-Vitro Diagnostics (IVD) market face?
Challenges include stringent regulatory requirements, the high cost of advanced diagnostic tests, reimbursement issues, and the need for skilled professionals to operate complex diagnostic equipment.
๐๐๐จ๐ฎ๐ญ ๐๐ฌ:
Fortune Business Insightsโข offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
๐๐จ๐ง๐ญ๐๐๐ญ ๐๐ฌ:
Fortune Business Insightsโข Pvt. Ltd.
9th Floor, Icon Tower,
Baner, Pune-411045,
Maharashtra, India.
Phone:
U.S.: US +1 833 909 2966 (Toll Free)
UK +44 808 502 0280 (Toll Free)
APAC +91 744 740 1245
Email: sales@fortunebusinessinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release In-vitro Diagnostics Market Size, Growth, Opportunities 2024-2032 | F. Hoffmann-La Roche Ltd, Abbott Laboratories, Thermo Fisher Scientific Inc., Sysmex Corporation, Siemens Healthineers AG, BD (Becton, Dickinson, and Company), Seegene Inc. (Republic of K here
News-ID: 3666839 • Views: โฆ
More Releases from Fortune Business Insights Pvt. Ltd.

Global Bread Maker Market to Reach USD 11.13 Billion by 2032, Driven by a 4.71% โฆ
The global bread maker market size was valued at USD 7.48 billion in 2023 and is expected to be worth USD 7.70 billion in 2024. The market is projected to reach USD 11.13 billion by 2032, recording a CAGR of 4.71% during the forecast period.
Bread maker machines enable users to create a diverse range of bread at home cost-effectively. The increasing demand for innovative home appliances and the rising replacementโฆ

Streetwear Industry to Reach $637.12 Billion by 2032 at 7.89% CAGR During Foreca โฆ
The global streetwear market size was valued at USD 325.28 billion in 2023. The market is projected to be worth USD 347.14 billion in 2024 and reach USD 637.13 billion by 2032, exhibiting a CAGR of 7.89% during the forecast period. Asia Pacific dominated the streetwear market with a market share of 36.17% in 2023.
Fortune Business InsightsTM displays this information in a report titled, "Streetwear Market, 2024-2032."
Request a Free Sampleโฆ

Streetwear Market Size, Share, Analysis, Overview, Demand, Report, 2032 | Compan โฆ
The streetwear market size was valued at USD 325.28 billion in 2023 and is expected to be worth USD 347.14 billion in 2024. The market is projected to reach USD 637.13 billion by 2032, recording a CAGR of 7.89% during the forecast period.
Streetwear is youth-inspired clothing that is highly popular among hip-hop enthusiasts and skateboarders. It is popular for its vibrant colors, bold logo graphics, and unconventional designs. Streetwear isโฆ

Perfume Market Size, Share, Growth, Demand, Overview, Report, 2032 | Companies- โฆ
The global perfume market size was valued at USD 48.05 billion in 2023 and is projected to grow from USD 50.45 billion in 2024 to USD 77.52 billion by 2032, exhibiting a CAGR of 5.51% during the forecast period.
Perfumes are pleasant smelling solutions made by using oils, fragrances, and other ingredients to create a pleasing aroma. Increasing demand for high-quality beauty and grooming products globally is expected to boost theโฆ
More Releases for IVD
Transformative Trends Impacting the Cancer In Vitro Diagnostics (IVD) Market Lan โฆ
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Cancer In Vitro Diagnostics (IVD) Market Size By 2025?
The market size for cancer in vitro diagnostics (IVD) has seen significant growth in the past few years. The market value, which is expected to be $13.36 billion in 2024, is projected to increase to $14.32โฆ
In Vitro Diagnostics (IVD) Market
With the watchful use of established and advanced tools such as SWOT analysis and Porter's Five Forces Analysis, this market report has been structured. While preparing this In Vitro Diagnostics (IVD) Market research report, few of the attributes that have been adopted include highest level of spirit, practical solutions, committed research and analysis, innovation, integrated approaches, and most up-to-date technology.
Every possible effort has been taken while researching and analysingโฆ
Companion Animal IVD Market - Guiding the Path to Optimal Health: Empowering Vet โฆ
Newark, New Castle, USA - new report, titled Companion Animal IVD Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Companion Animal IVD market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Companion Animal IVD market. The report offers an overview ofโฆ
IVD Market 2021 | Detailed Report
The IVD market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. The IVD report also incorporates the current and future global market outlook in the emerging and developed markets. Moreover, the report also investigates regions/countries expected to witness the fastest growth rates during the forecast period.
The IVD research report also provides insights of different regions that are contributing market growth.โฆ
Liquid Biopsy IVD Market 2021 | Detailed Report
According to Market Study Report, Liquid Biopsy IVD Market provides a comprehensive analysis of the Liquid Biopsy IVD Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample PDF (including full TOC, Tables and Figures) of Liquid Biopsy IVD Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4623688
The report provides aโฆ
Asia IVD Market
According to a new report published by Allied Market Research, the Asia Pacific In-vitro diagnostics market was valued at $12.9 billion in 2015, and is expected to reach $19.0 billion registering a CAGR of 5.6% during 2016 to 2022. The report offers a detailed analysis of the key segments, top investment pockets, changing dynamics, market size & estimations, and competitive scenario.
Download Free Sample Report @ https://www.alliedmarketresearch.com/request-sample/1256
The Asia-Pacific IVD market isโฆ